Utama › Skizofrenia › New York

Kajian klinikal Skizofrenia di New York

23 kajian untuk Skizofrenia sedang mencari peserta di lokasi di New York.

Bandar di New York

Teks kajian rasmi (Bahasa Inggeris)

iTBS to Enhance Social Cognition in People With Psychosis

Zucker Hillside Hospital, Glen Oaks

Mengambil peserta

Umur 18 hingga 39 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06118268

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

Radial - Manhattan, New York

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07101094

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

Neurobehavioral Research Inc, Cedarhurst
Evolution Research Group, Staten Island

Mengambil pesertaFasa 1

Umur 18 hingga 55 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07615426

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

NYU Child Study Center, New York
Richmond Behavioral Associates, Staten Island

Mengambil pesertaFasa 3

Umur 5 hingga 17 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06229210

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Neurocrine Clinical Site, Cedarhurst
Neurocrine Clinical Site, New York
Neurocrine Clinical Site, New York
dan 2 lagi

Mengambil pesertaFasa 3

Umur 18 hingga 65 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07114874

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

Neurocrine Clinical Site, Cedarhurst
Neurocrine Clinical Site, New York
Neurocrine Clinical Site, The Bronx

Mengambil pesertaFasa 3

Umur 18 hingga 65 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07227818

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

Local Institution - 0061, Great Neck
Local Institution - 0156, Staten Island
Local Institution - 0151, The Bronx

Mengambil pesertaFasa 3

Umur 5 hingga 17 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07424404

A Study of Brenipatide in Adult Participants With Schizophrenia

Adams Clinical Harlem, New York

Mengambil pesertaFasa 2

Umur 18 hingga 55 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07410507

52-week Open Label Safety-Tolerability Study

Neuro-Behavioral Clinical Research, New York

Mengambil pesertaFasa 3

Umur 18 hingga 65 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

Local Institution - 0061, Great Neck

Mengambil pesertaFasa 3

Umur 13 hingga 17 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07288567

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Clinical Site, New York
Clinical Site, Staten Island
Clinical Site, The Bronx

Mengambil pesertaFasa 2

Umur 18 hingga 65 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT07459647

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

Local Institution - 0037, Buffalo
Local Institution - 0004, Monsey
Local Institution - 0038, Rochester
dan 1 lagi

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT07379827

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Alkermes Investigator Site, New York

Mengambil pesertaFasa 3

Umur 10 hingga 17 · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT05303064

Biomarkers to Enhance Early Schizophrenia Treatment

Feinstein Institute for Medical Research, Glen Oaks

Mengambil pesertaFasa 4

Umur 18 hingga 35 · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06969755

MicroRNAs as Biomarkers in First Episode Schizophrenia

Zucker Hillside Hospital, Glen Oaks

Mengambil pesertaSukarelawan sihat dialu-alukan

Umur 15 hingga 40 · Semua jantina · Dikemas kini 14 Jul 2026 · NCT07703670

A Virtual Reality Mindfulness Application for Aggression in Schizophrenia

Manhattan Psychiatric Center, New York
NewYork-Presbyterian/Weill Cornell Medical Center Westchester Division, White Plains

Mengambil peserta

Umur 18 hingga 64 · Semua jantina · Dikemas kini 10 Jun 2026 · NCT07434479

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

NYU Langone Medical Center, New York
New York State Psychiatric Institute, New York
Manhattan Psychiatric Center, New York

Mengambil pesertaFasa 4

Umur 18 hingga 65 · Semua jantina · Dikemas kini 4 Mei 2026 · NCT05208190

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Neurocrine Clinical Site, Staten Island
Neurocrine Clinical Site, The Bronx

Mengambil pesertaFasa 3

Umur 18 hingga 65 · Semua jantina · Dikemas kini 6 Mac 2026 · NCT06963034

Randomized Withdrawal Study in Patients With Schizophrenia

Vanda Investigational Site, Staten Island

Mengambil pesertaFasa 3

Umur 18 hingga 65 · Semua jantina · Dikemas kini 12 Jan 2026 · NCT06961968

Study of ALTO-101 in Patients With Schizophrenia

Site 5108, New York
Site 5077, New York
Site 5126, White Plains

Mengambil pesertaFasa 2

Umur 21 hingga 55 · Semua jantina · Dikemas kini 26 Dis 2025 · NCT06502964

Visual Perception in Schizophrenia

University of Rochester, Rochester

Mengambil pesertaSukarelawan sihat dialu-alukan

Umur 18 hingga 65 · Semua jantina · Dikemas kini 12 Nov 2025 · NCT06911931

Effectiveness of Motivation Skills Training (MST)

The Bridge, Inc., New York
New York State Office of Mental Health, New York

Mengambil peserta

Umur 18 hingga 65 · Semua jantina · Dikemas kini 5 Nov 2025 · NCT05805397

Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study

Zucker Hillside Hospital, New York

Mengambil peserta

Umur 18 hingga 60 · Semua jantina · Dikemas kini 25 Sep 2025 · NCT05389787

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.